Phase IIb trial of in vivo electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy

AIM: To assess the efficacy and safety of in vivo electroporation (EP)-mediated dual-plasmid hepatitis B virus (HBV) DNA vaccine vs placebo for sequential combination therapy with lamivudine (LAM) in patients with chronic hepatitis B. METHODS: Two hundred and twenty-five patients were randomized to...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fu-Qiang, Rao, Gui-Rong, Wang, Gui-Qiang, Li, Yue-Qi, Xie, Yao, Zhang, Zhan-Qing, Deng, Cun-Liang, Mao, Qing, Li, Jun, Zhao, Wei, Wang, Mao-Rong, Han, Tao, Chen, Shi-Jun, Pan, Chen, Tan, De-Ming, Shang, Jia, Zhang, Ming-Xiang, Zhang, Yue-Xin, Yang, Ji-Ming, Chen, Guang-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Clinical Trials Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5236510/
https://www.ncbi.nlm.nih.gov/pubmed/28127204
http://dx.doi.org/10.3748/wjg.v23.i2.306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5236510/
https://www.ncbi.nlm.nih.gov/pubmed/28127204
http://dx.doi.org/10.3748/wjg.v23.i2.306

Ejemplares similares